Introduction: Increasing antibiotic resistance (ABR) in low and middle-income countries such as Bangladesh presents a major health threat. However, assessing the scale of the health risk is problematic in the absence of reliable data on the community prevalence of antibiotic-resistant bacteria. We describe the protocol for a small-scale integrated surveillance programme that aims to quantify the prevalence of colonisation with antibiotic resistant bacteria and concentrations of antibiotic resistant genes from a 'One Health' perspective. The holistic assessment of antibiotic resistance in humans, animals and within the environment in urban and rural Bangladesh will generate comprehensive data to inform human health risk.
• Seasonal and spatial variation on the occurrence of antibiotic resistant bacteria in humans, poultry and the wider environment will be assessed
• The two regions included in the study may not be typical of all regions within
INTRODUCTION
Antibiotic resistance (ABR) has been widely recognised as an emerging threat to human health and a global research priority for capacity development and public health campaigns in clinical and community settings (1) . Antimicrobial resistance is seen as a 'One Health' challenge (1) . That is, efforts are needed to tackle the problem of ABR in all three domains of humans, animals and in the wider environment in order to achieve optimal human health (2) .
The natural environment is acknowledged as an important reservoir of antibiotic resistant bacteria, with anthropogenic activities such as agriculture, antibiotic residues and wastewater disposal potentially enhancing the horizontal transfer of resistant genes (3, 4) . Genes for antibiotic resistance can survive in the environment, collectively known as the 'resistome', and the exchange of genetic material encoding for antimicrobial resistance can take place through mobile genetic elements such as plasmids via conjugation and other mechanisms in environmental compartments (5) .
Antimicrobials have been shown also induce the transfer of resistance determinants between microorganisms(6). These processes may be accelerated by the presence of environmental contaminants or pollutants such as heavy metals, antibiotic residues or biocides(7). However, it is not yet known to what extent these environmental sources of antibiotic resistance may be transmitted to humans. There is therefore a pressing need for research to quantify the extent of transmission of clinically relevant ABR bacteria from the environment to humans(8).
Resistance to third-generation cephalosporins is increasing as bacteria acquire the ability to produce extended-spectrum beta-lactamases (ESBLs). The prevalence of colonisation with ESBL-producing E. coli is estimated to be around 14% globally, with rates as high as 22% in Asia and sub-Saharan Africa(9). Of greater concern, Dhaka are known to carry high levels of sewage-derived bacteria (16) . Around 36%
of E. coli isolates from tap water samples in Dhaka city were reported to be multidrug resistant and 26% of these were positive for extended spectrum betalactamase, posing a serious threat to public health (16) . Drinking water contamination is also common in rural areas of Bangladesh; 59% of drinking water samples for children that were stored or directly obtained mostly from tubewells were positive for E. coli faecal contamination(17) but were not tested for resistant phenotypes.
Prospective sampling indicated that ingestion of contaminated water led to subsequent episodes of diarrhoea among children (17) . Approximately 3.5% of gramnegative clinical isolates in Bangladesh are NDM-1-producing (18) and faecal carriage of NDM-1-producing bacteria has been demonstrated among patients with diarrhoea(13,19).
The physical and social environment in Bangladesh favours the rapid spread of ABR with high density populations; lack of clean drinking water and poor sanitation infrastructure. Widespread faecal contamination in water and soil, as well as human hands and food has been demonstrated in microbiological studies in Bangladesh (20) . The availability of inexpensive antimicrobials from over-the-counter suppliers leads to inappropriate use of antibiotics (21) . The release of antimicrobials into the environment through drug manufacturing and poor waste disposal processes adds further complexities to the pathways for the selection and spread of resistance in the environment (22) . In Bangladesh, a high prevalence of bla NDM-1 genes has been found in hospital wastewater compared to community wastewater in the city of Dhaka, highlighting anthropogenic influences on ABR prevalence (23) .
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2.
To identify the selective drivers of ABR in three exposure-relevant outdoor environments: urban poultry markets; commercial poultry farms, and rural villages.
3.
To assess the transfer of resistance within and between microbial communities by comparing ABR carriage rates in humans with high and low exposure to environmental and animal reservoirs of ABR genes.
4.
To assess the anthropogenic influences on ABR in the natural environment though ethnographic research among poultry farmers, market sellers and village poultry owners. (27, 28) . Fresh food and poultry markets in Dhaka city are the largest outlets of commercial poultry where birds are slaughtered and processed on site with no regulated solid and liquid waste disposal system (29) . Faecal wastes produced within commercial farms and urban markets are mostly disposed into the environment through direct wash out (29) .
METHODS AND ANALYSIS
The conceptual framework for the study design and the sampling strategy are shown in Figure 1 . The study will generate robust data through a sampling framework targeting three distinct outdoor environments with a high potential for ABR transmission 1) urban live poultry markets in high density residential areas 2) commercial poultry farms in rural sites serving the urban retail market 3) rural villages with traditional animal husbandry and backyard poultry.
E. coli will be investigated as an indicator organism due to its reliability, ease of culturing, affordability, and relevance as a contributor to both diarrheal disease (e.g., diarrheagenic strains) and antibiotic resistance (e.g. multidrug resistant strains). E.
coli has been listed as a critically important organism for antimicrobial resistance by the WHO (30) . The bacterium is a normal resident of the intestinal tract of both human and animals as well as the environment, but pathogenic strains give rise to clinical disease in both hosts (31) . Hence, E. coli is widely used in studies of the environmental transmission of ABR, particularly for community-acquired resistance using a One Health approach(4). An interviewer-administered survey of participants will document common practices of domestic (rural) and commercial poultry holders (farmers and market sellers).
Domestic and commercial poultry owners and market sellers will be questioned 
Selection and recruitment of study participants
Human participants will be recruited to take part in the study on a voluntary basis and will be provided with information about the study. Only those who volunteer and provide their written informed consent will take part in surveys and provide a faecal sample. The sampling within live poultry markets will start from the centre of a market, omitting the first 10 eligible stalls, approaching the next eligible stall and asking the owner to participate. In this way, stallholders with high exposure and their poultry will be recruited. The low exposure group will comprise stallholders without domestic animal produce (e.g. those selling fruit/vegetables) in the same markets.
The same geographical sampling strategy will be used for household selection in villages to attain 10 poultry owning and 10 non-poultry owning households. Farms will be selected from a list registered with the Department of Livestock Services and access requested through the Upazila/District Livestock Officer. A low-risk comparison group of non-farm workers will be recruited from the same residential area as the farm workers. Three teams of two fieldworkers will collect samples and data in the wet (monsoon) and dry seasons. Supervision and coordination of fieldwork and laboratory analysis of samples will be carried out by an experienced research investigator. Data collection commenced in March 2017 and is ongoing.
Patient and Public Involvement
As this was a study of healthy adults in community settings, a patient group was not involved in the study design or research protocol. However, the study team consulted local community representatives prior to commencing fieldwork to discuss the research; consulted with the main local hospital, and liaised with local government staff in livestock services to discuss working with the poultry farm workers, as well as obtaining a list of registered commercial farms. This did not result in any direct changes to the protocol but confirmed that the intended methods and approaches were appropriate. Feedback on the research findings will be provided through open meetings in the communities as well as sharing with relevant stakeholders and users of the research as part of the planned dissemination activities. 
Sample collection for laboratory analysis
Poultry caecal samples Live chickens will be collected from rural households, poultry farms and live bird markets and slaughtered. After defeathering, the whole carcass will be placed in a sterile zipper bag. After transportation to the laboratory under a cool chain (4 o C to 8 o C) caecal samples will be collected aseptically from the dissected whole carcass.
Poultry faeces samples
Poultry litter samples will be collected from three different areas of the bird cage/container; floor (in cases where birds are kept in a confined area and not in a cage) or grounds of a compound for free-ranging animals and pooled in a sterile plastic bag and mixed thoroughly.
Solid waste samples
Solid waste samples will be collected from the municipal waste disposal sites near the markets. Samples will be collected from three different locations surrounding the waste collection area. A sterile spatula or spoon will be used to collect solid waste of soil from the same area will be placed into a cryovial with LifeGuard solution.
Waste water samples Waste water samples will be collected from three separate locations of the run-off drain adjacent to the farm, household or market and pooled together in a sterile plastic bottle (Nalgene, Rochester, NY). Approximately 300 ml of water will be collected from each point by submerging a sterile container into the drain and transferred to a 1000 ml sterile plastic bottle.
Surface water samples
Water samples from rivers, ponds or other surface water downstream of peri-urban and rural areas will be collected using a sterile plastic bottle. A bottle will be filled by plunging downwards about 30 cm below the water surface and resealed tightly to prevent leakage. Particular care will be taken to avoid bacterial contamination inside the bottle or cap from sources other than the water. Sample bottles will be transported to the laboratory within 8h of collection.
Supply water samples
To collect water sample from tubewells, the hand pump will be operated continuously for 5 minutes. The mouth of the pump will then be heated by means of a gas torch, followed by pumping several litres of water to waste. A sample of water will be collected aseptically by allowing the water from the pump to flow directly into a sterile bottle. After collection, the cap of the bottle will be replaced carefully.
To collect samples from taps, the outside nozzle of the tap will be cleaned carefully.
The tap will then be turned on full and the water allowed to run to waste for 1 minute.
The outside of the tap will be sterilized using the flame of a gas torch and allowed to cool by running the water to waste for a few seconds. The sterile sample bottle will be filled from a gentle flow of water and the cap placed on the bottle. Sample bottles will be transported to the laboratory within 8h of collection.
Human stool samples
Each study participant will be provided with a stool sample container and the procedure for the collection of samples will be explained. Field staff will pick up the sample container within 2 hours of collection. manufacturer's protocol supplied with the kit will be followed for extraction of DNA directly from samples.
Analysis of samples for detection and quantification of bla NDM-1 and bla CTX-M-1 genes by qPCR assay
The amplification and detection of the bla NDM-1 and bla CTX-M-1 genes will be carried out in a Bio-Rad CFX 96 real-time PCR platform by use of the TaqMan technology.
Primers and probe sequences and PCR programs for amplifying bla NDM-1 and bla CTX-M-1 genes will be designed in house using publicly available sequences in the NCBI genbank. For quantitation of copy number of genes, a standard curve will be generated using known concentrations of selected conserved sequence of both genes obtained from the NCBI genbank. Using standard gene sequences, gene concentrations will be determined spectrophotometrically using the Nanodrop ND 1000 instrument according to the manufacturer's instructions (Nanodrop, Wilmington, DE). DNA will be 10-fold serially diluted in nuclease-free water (100ng/microliter).
Standard curves will be generated using 10 2 to 10 7 copies of standard DNA.
Culture of samples for E. coli resistance to third generation cephalosporin or carbapenem
For human and poultry faeces, solid waste and soil samples, 1-5 g of sample will be weighed and dispensed into 9-45 ml of sterile PBS in a sterile Falcon tube. After vortexing on high speed for one minute, the suspension will be allowed to settle at For water supply samples (tap or tubewell), 2 x 100 ml of water will be passed separately through two 0.22 µm cellulose membrane filters and the filters will be placed in an upright position on three modified mTEC agar media (BD Difco ® ); one without any supplementation, one supplemented with cefotaxime (1 mg/L) and the other supplemented with meropenem (05 mg/L). The plates will be incubated at 37°C for 2h followed by 18h of incubation at 44°C. The remaining water samples will be kept at 4°C until the test is complete. If the number of colonies is >200 CFU then appropriate dilutions of the water sample will be made on the following day and the diluted sample will be inoculated on the same media and incubated as above. After incubation, blue colonies, typical of E. coli, will be counted. At least two isolated colonies will be extracted from each sample plate and subcultured onto MacConkey agar plate supplemented with the same antibiotic and incubated overnight at 37°C. A culture sweep will be taken from the MacConkey plate and suspended in TSB media with 30% glycerol supplemented with the same antibiotic and kept at -80°C until further use.
Confirmation of E. coli using API 20E
One E. coli isolate from each of the samples will be tested using the API20E kit (BioMérieux, France) for biochemical identification. For any sample where the Susceptibility testing will be carried out according to CLSI guidelines (32).
E
. coli isolates will be tested for genetic fingerprinting using random amplified polymorphic DNA (RAPD) analysis following the procedure described earlier (33).
Isolates will be clustered based on the RAPD banding pattern along with their antibiotic susceptibility patterns. Representative clones from each of the clusters will be analysed further for whole genome sequencing using Illumina MiSeq platform, which allows paired-end, long-read analysis of up to 40 DNA samples per lane. Data will be analysed by an automated custom bioinformatics pipeline.
Sample size justification
The primary outcome of the study is the prevalence of third generation cephalosporin and carbapenem antibiotic resistant E. coli isolates and the concentration of ESBL and carbapenem resistance genes in environmental, human and poultry faecal samples.
As a baseline surveillance study to establish the prevalence of resistant bacteria and resistance genes we have not made an a priori assumption based on the expected difference between high and low exposure groups, or wet and dry season prevalence rates, but this research has been informed by leading research in the field(4). The sampling framework is designed to characterise the extent of variability in ABR by selecting 20 farms, 20 markets and 10 villages in each data collection survey (totalling 40 farms, 40 markets and 20 villages over two surveys), which will reduce the likelihood of sampling bias.
Data Analysis
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• Logistic regression will be carried out to determine whether there are significant differences in the prevalence of colonisation with ESBLproducing or carbapenem resistant E. coli and concentrations of resistance genes in human groups with high and low exposure to environmental contamination and poultry.
• Generalised linear models with robust standard errors will be used to identify predictors of colonisation with antibiotic resistant E. coli in humans such as location (farm, market or rural), occupational exposure, antibiotic use and consumption, and season (wet versus dry) controlling for geographical clustering.
• Analysis of variance (or non-parametric equivalent) will be used to compare the concentrations of resistant bacteria and genes in upstream, wastewater and downstream locations, with spatial mapping of resistant bacteria and gene concentrations.
• A qualitative synthesis will be carried out on the drivers of antibiotic use for poultry by analysis of in-depth interviews with farmers, domestic poultry owners and live bird market workers.
• Logistic regression analysis will be used to compare human exposure-risk behaviours such as handling of poultry, disposal of poultry faeces, contact with poultry carcasses and solid or liquid waste disposal in each location (markets, farms and rural villages). Data from the project will be hosted by the Environmental Information Data Centre,
ETHICS AND DISSEMINATION

This
Centre for Ecology and Hydrology in line with the data management plan. The results of this study will be published in peer-reviewed journals in the fields of global The research team will follow institutional guidelines on the involvement of human participants and ensure that their rights are protected. We will invite healthy adults (>18 years) to participate in the study, and the study has been designed to be minimally invasive (collection of one stool sample per person) and to take as little time and cause as minimal inconvenience as possible (approximately 20 minutes for an interviewer-administered questionnaire survey). Observational reports on poultrykeeping, selling and slaughtering practices will be carried out in ways that avoid intruding on the daily activities of participants.
Participants will be informed that their involvement is voluntary. The purpose of the study, what would be involved in taking part in the study, and the method of collection of faecal samples from participants will be explained in detail in the participant information sheet written in Bangla, and participants will be given opportunities to ask questions or seek clarification. Information about the study will be provided in the form of a participant information letter in Bangla (to be read verbally and given in writing to participants). A written informed consent form in Bangla will be obtained from the participants to indicate willingness to take part.
Participants will be informed of their right to withdraw from the study. To ensure anonymity, all survey responses and stool samples will be allocated a unique study identification number. No personal identifying details will be kept with either the samples or the survey data.
CONCLUSION
This study will provide important baseline data from Bangladesh on the colonisation rates of healthy humans with antibiotic resistant E. coli. Linking human colonisation to occupational and exposure risks from animals and the environment, with simultaneous assessment of resistant bacteria and genes in all environmental compartments, will help to identify and quantify the hotspots for antibiotic-resistant bacteria and antibiotic-resistant genes and the potential risks to human health. Footnote to Figure 1 : In each site, one sampling round will be conducted in the dry season (n=20 markets; n=20 farms; n=20 households) and another sampling round in the wet season (an additional n=20 markets; n=20 farms; n=20 households). In each site, one sampling round will be conducted in the dry season (n=20 markets; n=20 farms; n=20 households) and another sampling round in the wet season (an additional n=20 markets; n=20 farms; n=20 households).
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